Follow The Filings

ESAB

Earnings company data as of 4:46 AM ET 10/24

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 4 Nov EPS 1.32 — —
Rev — — —

Insider trades

Open-market buys and sales by ESAB's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ESAB insider trades
  • None no insider bought on the open market
  • $414K sold by 2 insiders outside a trading plan
  • $8.4M sold by 3 insiders under 10b5-1 plans
  1. Rhonda L Jordan Director
    Sale
    $95K 1,000 shares at $95.00 100% of stake
    Traded Aug 7 Filed Aug 10
  2. Michele Campion Chief Human Resources Officer
    Planned sale
    $625K 5,096 shares at $122.63 31% of stake
    Traded Feb 27 Filed Mar 2
  3. Shyam Kambeyanda CEO
    Planned sale
    $7.4M 59,404 shares at $123.79 37% of stake
    Traded Feb 23 Filed Feb 25
  4. Kevin J Johnson CFO
    Planned sale
    $470K 3,494 shares at $134.62 12% of stake
    Traded Feb 6 Filed Feb 9
  5. Rajiv Vinnakota Director
    Sale
    $319K 2,783 shares at $114.50 24% of stake
    Traded Nov 11, 2025 Filed Nov 13, 2025

Also filed in the last 12 months, not counted as buying or selling: 35 option exercises, 33 share withholdings for taxes, 10 stock grants, 3 gifts, and 2 other transactions.

SEC filings

Recent issuer filings from EDGAR, 11 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
SCHEDULE 13G/A —
8-K 2.02,9.01
10-Q
8-K/A 9.01
SCHEDULE 13G —
424B7 PROSPECTUS SUPPLEMENT
8-K 5.02,9.01
SCHEDULE 13D/A —
8-K 2.01,3.02,3.03,5.03,7.01,8.01,9.01
8-K 5.07

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.